COSTEM Congress

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

COSTEM Congress

Oct 29, 2024, 09:22 | Blog

Johanna Richter: Shaping future decisions in stem cell transplantation and cellular therapies

Johanna Richter shared a post on X: "Amazing format for shaping future decisions in stem cell…

Oct 21, 2024, 15:40 | Blog

Do CAR T cells replace autologous SCT in autoimmune disease? - COSTEM Congress

COSTEM Congress posted on X: "Controversy: Do CAR T cells replace autologous SCT in autoimmune…

Oct 14, 2024, 16:58 | Blog

Do we need allogeneic HSCT consolidation after CD19 CAR T therapy for pediatric ALL? - COSTEM Congress

COSTEM Congress posted on X: "Do we need allogeneic HSCT consolidation after CD19 CAR T…

Oct 1, 2024, 16:02 | Insight

Anna Sureda and Ali Bazarbachi in the upcoming COSTEM congress

COSTEM Congress shared on X: “We're looking forward to hearing from Anna Sureda and Ali…

Aug 13, 2024, 14:03 | Societies

Should all FMS-like (FLT3)-positive AML receive maintenance therapy post-allograft? - COSTEM Congress

COSTEM Congress shared on X: "We're looking forward to hearing from Andreas Burchert and Arnon…

All: 5 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023